| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.091 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |